Insider · CIK 0001805688

Pearce Samantha

Reports to the SEC for 1 company · DUBLIN 4

sec.gov

Transactions

Companies

Filings

CIK

0001805688

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−780 sh	$261.62	−$204K	47,131
2026-06-30	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−2,527 sh	$237.72	−$601K	47,911
2026-05-28	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+6,907 sh	$109.45	+$756K	57,179
2026-05-28	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−6,907 sh	$235.41	−$1.63M	50,272
2026-05-28	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−6,907 sh	—	—	0
2026-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−2,503 sh	$188.69	−$472K	50,272
2026-02-26	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+9,782 sh	—	—	52,775
2026-01-16	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+3,637 sh	—	—	44,592
2026-01-16	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−1,599 sh	$171.16	−$274K	42,993
2025-08-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−577 sh	$116.10	−$67K	40,815
2025-03-05	JAZZJazz Pharmaceuticals plcD Disposition to Issuer	EVP, Chief Commercial Officer	DDisposition to Issuer	−1,905 sh	$138.95	−$265K	41,226
2025-02-27	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+11.9K sh	—	—	37,353
2025-02-27	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+5,778 sh	—	—	43,131
2025-01-17	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+2,533 sh	—	—	26,777
2025-01-17	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−1,365 sh	$122.62	−$167K	25,412
2024-08-02	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+6,996 sh	—	—	24,078
2024-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−2,474 sh	$117.53	−$291K	16,922
2024-03-01	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+5,065 sh	—	—	19,396
2024-01-17	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+2,210 sh	—	—	15,369
2024-01-17	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−1,038 sh	$119.13	−$124K	14,331
2023-03-05	JAZZJazz Pharmaceuticals plcF Tax Payment	EVP, Chief Commercial Officer	FTax Payment	−2,020 sh	$142.78	−$288K	13,159
2023-03-03	JAZZJazz Pharmaceuticals plcA Award	EVP, Chief Commercial Officer	AAward	+3,870 sh	—	—	15,179
2023-02-02	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+531 sh	$109.45	+$58.1K	11,840
2023-02-02	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−531 sh	$157.26	−$83.5K	11,309
2023-02-02	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−531 sh	—	—	6,907
2023-01-03	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+531 sh	$109.45	+$58.1K	11,840
2023-01-03	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−531 sh	$159.59	−$84.7K	11,309
2023-01-03	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−531 sh	—	—	7,438
2022-12-13	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+531 sh	$109.45	+$58.1K	11,840
2022-12-13	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−531 sh	$155.45	−$82.5K	11,309
2022-12-13	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−531 sh	—	—	7,969
2022-11-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+532 sh	$109.45	+$58.2K	11,841
2022-11-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−532 sh	$155.00	−$82.5K	11,309
2022-11-10	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+531 sh	$109.45	+$58.1K	11,840
2022-11-10	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−531 sh	$155.00	−$82.3K	11,309
2022-11-10	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−532 sh	—	—	9,031
2022-11-10	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−531 sh	—	—	8,500
2022-09-02	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+531 sh	$109.45	+$58.1K	11,840
2022-09-02	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−531 sh	$156.98	−$83.4K	11,309
2022-09-02	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−531 sh	—	—	9,563
2022-08-04	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+531 sh	$109.45	+$58.1K	11,840
2022-08-04	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−531 sh	$155.00	−$82.3K	11,309
2022-08-04	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−531 sh	—	—	10,094
2022-07-12	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+532 sh	$109.45	+$58.2K	11,841
2022-07-12	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−532 sh	$155.00	−$82.5K	11,309
2022-07-12	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−532 sh	—	—	10,625
2022-06-27	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+8,508 sh	$109.45	+$931K	19,817
2022-06-27	JAZZJazz Pharmaceuticals plcS Sale	EVP, Chief Commercial Officer	SSale	−8,508 sh	$155.00	−$1.32M	11,309
2022-06-27	JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	−8,508 sh	—	—	11,157
2022-06-08	JAZZJazz Pharmaceuticals plcM Exercise/Conversion	EVP, Chief Commercial Officer	MExercise/Conversion	+5,835 sh	$109.45	+$639K	19,796

Recent filings

Accepted (ET)
Aug 74
Pearce Samantha0001805688-26-000014
SEC(opens sec.gov)
Jul 24
Pearce Samantha0001805688-26-000012
SEC(opens sec.gov)
Jun 14
Pearce Samantha0001805688-26-000008
SEC(opens sec.gov)
Mar 94
Pearce Samantha0001805688-26-000006
SEC(opens sec.gov)
Mar 24
Pearce Samantha0001805688-26-000004
SEC(opens sec.gov)
Jan 214
Pearce Samantha0001805688-26-000002
SEC(opens sec.gov)
Aug 74
Pearce Samantha0001765581-25-000051
SEC(opens sec.gov)
Mar 74
Pearce Samantha0001765581-25-000029
SEC(opens sec.gov)
Mar 34
Pearce Samantha0001765581-25-000016
SEC(opens sec.gov)
Jan 224
Pearce Samantha0001805688-25-000003
SEC(opens sec.gov)
Aug 64
Pearce Samantha0001765581-24-000072
SEC(opens sec.gov)
Mar 74
Pearce Samantha0001765581-24-000035
SEC(opens sec.gov)
Mar 54
Pearce Samantha0001765581-24-000022
SEC(opens sec.gov)
Jan 194
Pearce Samantha0001784606-24-000012
SEC(opens sec.gov)

Companies

Jazz Pharmaceuticals plcEVP, Chief Commercial OfficerJAZZ

Address

5TH FL, WATERLOO EXCHANGE WATERLOO RD

DUBLIN 4